Table 1. Comparisons of Group L and Group H clinical features.
| Group L (n = 289) | Group H (n = 273) | P-value | |
| Age (years) | 67.2±14.7 | 68.1±13.7 | 0.437 |
| Male gender (n, %) | 148 (51.2) | 191 (70.0) | <0.001 |
| Body mass index (kg/m2) | 23.1±4.2 | 23.3±4.1 | 0.496 |
| Systolic blood pressure (mmHg) | 121.3±17.9 | 117.8±19.7 | 0.125 |
| Diastolic blood pressure (mmHg) | 72.1±11.2 | 72.4±12.0 | 0.868 |
| Heart rate (bpm) | 67.5±13.9 | 71.6±14.8 | 0.018 |
| Ischemic etiology (n, %) | 76 (26.3) | 67 (24.5) | 0.698 |
| Co-morbidity | |||
| Hypertension (n, %) | 203 (70.2) | 205 (75.1) | 0.219 |
| Diabetes (n, %) | 91 (31.5) | 107 (39.2) | 0.064 |
| Dyslipidemia (n, %) | 208 (72.0) | 200 (73.3) | 0.777 |
| Atrial fibrillation (n, %) | 92 (31.8) | 118 (43.2) | 0.007 |
| Anemia (n, %) | 120 (41.5) | 168 (61.5) | <0.001 |
| Medications | |||
| ACE inhibitors/ARB (n, %) | 217 (75.1) | 191 (70.0) | 0.186 |
| β-blockers (n, %) | 209 (72.3) | 218 (79.9) | 0.068 |
| Diuretics (n, %) | 170 (58.8) | 165 (60.4) | 0.731 |
| Aldosterone blockers (n, %) | 117 (40.5) | 114 (41.8) | 0.797 |
| Warfarin/anti coagulation (n, %) | 144 (49.8) | 146 (53.5) | 0.399 |
| Laboratory data | |||
| White blood cell (×103/µl) | 7.30±3.38 | 7.52±3.35 | 0.454 |
| Platelet (×103/µl) | 18.1±6.5 | 19.6±7.5 | 0.019 |
| Hemoglobin (g/dl) | 12.7±2.1 | 11.9±2.7 | <0.001 |
| Prothrombin time-international ratio | 1.39±0.64 | 1.50±0.86 | 0.135 |
| BNP (pg/ml) † | 236.9 (457) | 517.1 (1069) | <0.001 |
| Blood urea nitrogen (mg/dl) | 24.4±13.3 | 23.0±12.9 | 0.239 |
| Creatinine (mg/dl) | 0.80±0.18 | 2.05±1.05 | <0.001 |
| eGFR (ml/min/1.73 cm2) | 71.0±18.1 | 40.4±21.9 | <0.001 |
| Uric acid (mg/dl) | 6.8±2.1 | 6.5±2.3 | 0.146 |
| Total protein (g/dl) | 7.0±0.8 | 6.8±0.8 | 0.014 |
| Albumin (g/dl) | 3.7±0.6 | 3.4±0.6 | <0.001 |
| Total bilirubin (mg/dl) | 0.8±0.3 | 1.2±0.7 | <0.001 |
| Direct bilirubin (mg/dl) | 0.1±0.0 | 0.2±0.1 | <0.001 |
| Aspartate aminotransferase (U/L) | 51.6±17.5 | 52.5±18.7 | 0.703 |
| Alanine aminotransferase (U/L) | 36.5±26.3 | 43.4±18.6 | 0.345 |
| Alkaline phosphatase (U/L) | 258.1±121.3 | 297.3±150.8 | <0.001 |
| Gamma-glutamyl transferase (U/L) | 59.4±32.9 | 76.8±41.9 | 0.033 |
| Cholinesterase (U/L) | 273.3±82.6 | 227.0±78.9 | <0.001 |
| Sodium (mEq/l) | 138.8±4.5 | 138.9±3.8 | 0.787 |
| C-reactive protein (mg/dl) † | 0.35 (1) | 0.37 (1) | 0.661 |
ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BNP, B-type natriuretic peptide; eGFR, estimated glomerular filtration.
†
Data are presented as median (interquartile range).